Effect of Type 2 Diabetes Mellitus on Mandibular Bone Regeneration and the Expression of T Helper Cell 17/regulat-ory T Cell-related Factors in Mice

Overview

Journal Hua Xi Kou Qiang Yi Xue Za Zhi

Specialty Dentistry

Date 2021 Dec 3

PMID 34859623

Citations 1

Authors

Ya Nan Wang

Xuan Wu

Ting Ting Jia

Yao Feng

Shi Yue Liu

Xin Xu

Dong Jiao Zhang

Affiliations

Soon will be listed here.

Abstract

Objectives: To observe the effect of type 2 diabetes mellitus (T2DM) on mandibular bone regeneration and the expression of factors related to T helper cell 17 (Th17 cell) and regulatory T cell (Treg cell) in mice.

Methods: Thirty-six 6-week-old C57BL/6J male mice were randomly divided into normal control (NC) and T2DM groups. Fasting blood glucose levels were detected 0 d, 7 d, 14 d, and 28 d after surgery for mandibular defects. Hematoxylin-eosin (HE) staining was used in observing the bone after 7 d, 14 d, and 28 d of the healing process. Immunohistochemical staining was used in observing the expression of alkaline phosphatase (ALP), Runt-related transcription factor 2 (RUNX2), forkhead box protein P3 (Foxp3), retinoic acid related orphan receptor gamma T (RORγt), and protein tyrosine phosphatase non-receptor type 2 (PTPN2) after 7 d, 14 d, and 28 d of healing.

Results: HE staining showed that the area with new bones in the T2DM group was significantly smaller than that in the NC group. Immunohistochemical staining showed that the expression of osteogenesis related proteins ALP and RUNX2 were significantly reduced in the T2DM group. In addition, the number of RORγt positive cells increased, whereas the number of Foxp3 positive cells and the expression PTPN2 decreased significantly in the mandibular bone defect in mice with T2DM.

Conclusions: T2DM significantly inhibit mandibular bone regeneration in mice. Decline in PTPN2 expression and the transition of Treg and Th17 may be the underlying molecular mechanisms.

Citing Articles

Protein tyrosine phosphatase non-receptor type 2 as the therapeutic target of atherosclerotic diseases: past, present and future.

Tang X, Cheng Y, Tang C Front Pharmacol. 2023; 14:1219690.

PMID: 37670950 PMC: 10475599. DOI: 10.3389/fphar.2023.1219690.

References

Wang Y, Jia T, Zhang J, Lan J, Zhang D, Xu X . PTPN2 improves implant osseointegration in T2DM via inducing the dephosphorylation of ERK. Exp Biol Med (Maywood). 2019; 244(16):1493-1503. PMC: 6900706. DOI: 10.1177/1535370219883419. View

Yin Y, Hao H, Cheng Y, Zang L, Liu J, Gao J . Human umbilical cord-derived mesenchymal stem cells direct macrophage polarization to alleviate pancreatic islets dysfunction in type 2 diabetic mice. Cell Death Dis. 2018; 9(7):760. PMC: 6037817. DOI: 10.1038/s41419-018-0801-9. View

Wen J, Liu Q, Liu M, Wang B, Li M, Wang M . Increasing Imbalance of Treg/Th17 Indicates More Severe Glucose Metabolism Dysfunction in Overweight/obese Patients. Arch Med Res. 2020; 52(3):339-347. DOI: 10.1016/j.arcmed.2020.11.012. View

Heilmeier U, Patsch J . Diabetes and Bone. Semin Musculoskelet Radiol. 2016; 20(3):300-304. DOI: 10.1055/s-0036-1592366. View

van Vliet C, Bukczynska P, Puryer M, Sadek C, Shields B, Tremblay M . Selective regulation of tumor necrosis factor-induced Erk signaling by Src family kinases and the T cell protein tyrosine phosphatase. Nat Immunol. 2005; 6(3):253-60. DOI: 10.1038/ni1169. View

Samuel R, Ervolino E, De Azevedo Queiroz I, Azuma M, Ferreira G, Cintra L . Th1/Th2/Th17/Treg Balance in Apical Periodontitis of Normoglycemic and Diabetic Rats. J Endod. 2019; 45(8):1009-1015. DOI: 10.1016/j.joen.2019.05.003. View

Zhang C, Xiao C, Wang P, Xu W, Zhang A, Li Q . The alteration of Th1/Th2/Th17/Treg paradigm in patients with type 2 diabetes mellitus: Relationship with diabetic nephropathy. Hum Immunol. 2014; 75(4):289-96. DOI: 10.1016/j.humimm.2014.02.007. View

Yamamoto M, Sugimoto T . Advanced Glycation End Products, Diabetes, and Bone Strength. Curr Osteoporos Rep. 2016; 14(6):320-326. PMC: 5104767. DOI: 10.1007/s11914-016-0332-1. View

Dodd G, Lee-Young R, Bruning J, Tiganis T . TCPTP Regulates Insulin Signaling in AgRP Neurons to Coordinate Glucose Metabolism With Feeding. Diabetes. 2018; 67(7):1246-1257. DOI: 10.2337/db17-1485. View

10.

Parlato M, Nian Q, Charbit-Henrion F, Ruemmele F, Rodrigues-Lima F, Cerf-Bensussan N . Loss-of-Function Mutation in PTPN2 Causes Aberrant Activation of JAK Signaling Via STAT and Very Early Onset Intestinal Inflammation. Gastroenterology. 2020; 159(5):1968-1971.e4. DOI: 10.1053/j.gastro.2020.07.040. View

11.

Ivanov I, McKenzie B, Zhou L, Tadokoro C, Lepelley A, Lafaille J . The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell. 2006; 126(6):1121-33. DOI: 10.1016/j.cell.2006.07.035. View

12.

Paschou S, Dede A, Anagnostis P, Vryonidou A, Morganstein D, Goulis D . Type 2 Diabetes and Osteoporosis: A Guide to Optimal Management. J Clin Endocrinol Metab. 2017; 102(10):3621-3634. DOI: 10.1210/jc.2017-00042. View

13.

Zhu L, Hua F, Ding W, Ding K, Zhang Y, Xu C . The correlation between the Th17/Treg cell balance and bone health. Immun Ageing. 2020; 17:30. PMC: 7557094. DOI: 10.1186/s12979-020-00202-z. View

14.

Zheng Y, Ley S, Hu F . Global aetiology and epidemiology of type 2 diabetes mellitus and its complications. Nat Rev Endocrinol. 2017; 14(2):88-98. DOI: 10.1038/nrendo.2017.151. View

15.

Spalinger M, Kasper S, Chassard C, Raselli T, Frey-Wagner I, Gottier C . PTPN2 controls differentiation of CD4⁺ T cells and limits intestinal inflammation and intestinal dysbiosis. Mucosal Immunol. 2014; 8(4):918-29. DOI: 10.1038/mi.2014.122. View

16.

Li Y, Zhou H, Wang F, Han L, Liu M, Li Y . Overexpression of PTPN2 in Visceral Adipose Tissue Ameliorated Atherosclerosis via T Cells Polarization Shift in Diabetic Apoe-/- Mice. Cell Physiol Biochem. 2018; 46(1):118-132. DOI: 10.1159/000488415. View

17.

Simoncic P, Nestel F, Duplay P, LAPP W, Tremblay M . The T-cell protein tyrosine phosphatase. Semin Immunol. 2000; 12(4):379-86. DOI: 10.1006/smim.2000.0220. View